Cargando…

Systemic treatment of metastatic hormone-sensitive prostate cancer—upfront triplet versus doublet combination therapy

Detalles Bibliográficos
Autores principales: Oing, C., Bristow, R.G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040503/
https://www.ncbi.nlm.nih.gov/pubmed/36947986
http://dx.doi.org/10.1016/j.esmoop.2023.101194
_version_ 1784912486188711936
author Oing, C.
Bristow, R.G.
author_facet Oing, C.
Bristow, R.G.
author_sort Oing, C.
collection PubMed
description
format Online
Article
Text
id pubmed-10040503
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-100405032023-03-28 Systemic treatment of metastatic hormone-sensitive prostate cancer—upfront triplet versus doublet combination therapy Oing, C. Bristow, R.G. ESMO Open Pro and Con Discussions Elsevier 2023-03-21 /pmc/articles/PMC10040503/ /pubmed/36947986 http://dx.doi.org/10.1016/j.esmoop.2023.101194 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Pro and Con Discussions
Oing, C.
Bristow, R.G.
Systemic treatment of metastatic hormone-sensitive prostate cancer—upfront triplet versus doublet combination therapy
title Systemic treatment of metastatic hormone-sensitive prostate cancer—upfront triplet versus doublet combination therapy
title_full Systemic treatment of metastatic hormone-sensitive prostate cancer—upfront triplet versus doublet combination therapy
title_fullStr Systemic treatment of metastatic hormone-sensitive prostate cancer—upfront triplet versus doublet combination therapy
title_full_unstemmed Systemic treatment of metastatic hormone-sensitive prostate cancer—upfront triplet versus doublet combination therapy
title_short Systemic treatment of metastatic hormone-sensitive prostate cancer—upfront triplet versus doublet combination therapy
title_sort systemic treatment of metastatic hormone-sensitive prostate cancer—upfront triplet versus doublet combination therapy
topic Pro and Con Discussions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040503/
https://www.ncbi.nlm.nih.gov/pubmed/36947986
http://dx.doi.org/10.1016/j.esmoop.2023.101194
work_keys_str_mv AT oingc systemictreatmentofmetastatichormonesensitiveprostatecancerupfronttripletversusdoubletcombinationtherapy
AT bristowrg systemictreatmentofmetastatichormonesensitiveprostatecancerupfronttripletversusdoubletcombinationtherapy